Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-13

FDA Approved: ANTI DIARRHEAL — Supplemental Application (H E B)

View source ↗

Summary

FDA approved a supplemental application for a generic anti-diarrheal drug containing loperamide hydrochloride (LOPERAMIDE HCL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOPERAMIDE HCL (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for ANTI DIARRHEAL (LOPERAMIDE HCL)